0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vivo Preclinical Brain Imaging Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-29L16772
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global In Vivo Preclinical Brain Imaging Devices Market Research Report 2024
BUY CHAPTERS

Global In Vivo Preclinical Brain Imaging Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-29L16772
Report
November 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In Vivo Preclinical Brain Imaging Devices Market

The global In Vivo Preclinical Brain Imaging Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Alzheimer's Disease accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
In Vivo Preclinical Brain Imaging Devices leading manufacturers including FUJIFILM Corporation, Mediso, Spectral Instruments Imaging, MR Solutions, Charles River Laboratories, Aspect Imaging, Bruker, MILabs, Cubresa, etc., dominate supply; the top five capture approximately % of global revenue, with FUJIFILM Corporation leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global In Vivo Preclinical Brain Imaging Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of In Vivo Preclinical Brain Imaging Devices Market Report

Report Metric Details
Report Name In Vivo Preclinical Brain Imaging Devices Market
Segment by Type
  • MRI
  • PET/SPECT
  • CT
  • Other
Segment by Application
  • Alzheimer's Disease
  • Parkinson's Disease
  • Oncology
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM Corporation, Mediso, Spectral Instruments Imaging, MR Solutions, Charles River Laboratories, Aspect Imaging, Bruker, MILabs, Cubresa
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the In Vivo Preclinical Brain Imaging Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the In Vivo Preclinical Brain Imaging Devices Market report?

Ans: The main players in the In Vivo Preclinical Brain Imaging Devices Market are FUJIFILM Corporation, Mediso, Spectral Instruments Imaging, MR Solutions, Charles River Laboratories, Aspect Imaging, Bruker, MILabs, Cubresa

What are the Application segmentation covered in the In Vivo Preclinical Brain Imaging Devices Market report?

Ans: The Applications covered in the In Vivo Preclinical Brain Imaging Devices Market report are Alzheimer's Disease, Parkinson's Disease, Oncology, Other

What are the Type segmentation covered in the In Vivo Preclinical Brain Imaging Devices Market report?

Ans: The Types covered in the In Vivo Preclinical Brain Imaging Devices Market report are MRI, PET/SPECT, CT, Other

1 Study Coverage
1.1 Introduction to In Vivo Preclinical Brain Imaging Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global In Vivo Preclinical Brain Imaging Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 MRI
1.2.3 PET/SPECT
1.2.4 CT
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global In Vivo Preclinical Brain Imaging Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Alzheimer's Disease
1.3.3 Parkinson's Disease
1.3.4 Oncology
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global In Vivo Preclinical Brain Imaging Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global In Vivo Preclinical Brain Imaging Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global In Vivo Preclinical Brain Imaging Devices Sales Estimates and Forecasts 2020-2031
2.4 Global In Vivo Preclinical Brain Imaging Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global In Vivo Preclinical Brain Imaging Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global In Vivo Preclinical Brain Imaging Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 MRI Market Size by Manufacturers
3.5.2 PET/SPECT Market Size by Manufacturers
3.5.3 CT Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global In Vivo Preclinical Brain Imaging Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global In Vivo Preclinical Brain Imaging Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global In Vivo Preclinical Brain Imaging Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global In Vivo Preclinical Brain Imaging Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global In Vivo Preclinical Brain Imaging Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Type (2020-2031)
6.4 North America In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America In Vivo Preclinical Brain Imaging Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Type (2020-2031)
7.4 Europe In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe In Vivo Preclinical Brain Imaging Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific In Vivo Preclinical Brain Imaging Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America In Vivo Preclinical Brain Imaging Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa In Vivo Preclinical Brain Imaging Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa In Vivo Preclinical Brain Imaging Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 FUJIFILM Corporation
11.1.1 FUJIFILM Corporation Corporation Information
11.1.2 FUJIFILM Corporation Business Overview
11.1.3 FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.1.4 FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices Sales by Product in 2024
11.1.6 FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices Sales by Application in 2024
11.1.7 FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices Sales by Geographic Area in 2024
11.1.8 FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices SWOT Analysis
11.1.9 FUJIFILM Corporation Recent Developments
11.2 Mediso
11.2.1 Mediso Corporation Information
11.2.2 Mediso Business Overview
11.2.3 Mediso In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.2.4 Mediso In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Mediso In Vivo Preclinical Brain Imaging Devices Sales by Product in 2024
11.2.6 Mediso In Vivo Preclinical Brain Imaging Devices Sales by Application in 2024
11.2.7 Mediso In Vivo Preclinical Brain Imaging Devices Sales by Geographic Area in 2024
11.2.8 Mediso In Vivo Preclinical Brain Imaging Devices SWOT Analysis
11.2.9 Mediso Recent Developments
11.3 Spectral Instruments Imaging
11.3.1 Spectral Instruments Imaging Corporation Information
11.3.2 Spectral Instruments Imaging Business Overview
11.3.3 Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.3.4 Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices Sales by Product in 2024
11.3.6 Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices Sales by Application in 2024
11.3.7 Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices Sales by Geographic Area in 2024
11.3.8 Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices SWOT Analysis
11.3.9 Spectral Instruments Imaging Recent Developments
11.4 MR Solutions
11.4.1 MR Solutions Corporation Information
11.4.2 MR Solutions Business Overview
11.4.3 MR Solutions In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.4.4 MR Solutions In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 MR Solutions In Vivo Preclinical Brain Imaging Devices Sales by Product in 2024
11.4.6 MR Solutions In Vivo Preclinical Brain Imaging Devices Sales by Application in 2024
11.4.7 MR Solutions In Vivo Preclinical Brain Imaging Devices Sales by Geographic Area in 2024
11.4.8 MR Solutions In Vivo Preclinical Brain Imaging Devices SWOT Analysis
11.4.9 MR Solutions Recent Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Corporation Information
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.5.4 Charles River Laboratories In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Charles River Laboratories In Vivo Preclinical Brain Imaging Devices Sales by Product in 2024
11.5.6 Charles River Laboratories In Vivo Preclinical Brain Imaging Devices Sales by Application in 2024
11.5.7 Charles River Laboratories In Vivo Preclinical Brain Imaging Devices Sales by Geographic Area in 2024
11.5.8 Charles River Laboratories In Vivo Preclinical Brain Imaging Devices SWOT Analysis
11.5.9 Charles River Laboratories Recent Developments
11.6 Aspect Imaging
11.6.1 Aspect Imaging Corporation Information
11.6.2 Aspect Imaging Business Overview
11.6.3 Aspect Imaging In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.6.4 Aspect Imaging In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aspect Imaging Recent Developments
11.7 Bruker
11.7.1 Bruker Corporation Information
11.7.2 Bruker Business Overview
11.7.3 Bruker In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.7.4 Bruker In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bruker Recent Developments
11.8 MILabs
11.8.1 MILabs Corporation Information
11.8.2 MILabs Business Overview
11.8.3 MILabs In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.8.4 MILabs In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 MILabs Recent Developments
11.9 Cubresa
11.9.1 Cubresa Corporation Information
11.9.2 Cubresa Business Overview
11.9.3 Cubresa In Vivo Preclinical Brain Imaging Devices Product Models, Descriptions and Specifications
11.9.4 Cubresa In Vivo Preclinical Brain Imaging Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Cubresa Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 In Vivo Preclinical Brain Imaging Devices Industry Chain
12.2 In Vivo Preclinical Brain Imaging Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 In Vivo Preclinical Brain Imaging Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 In Vivo Preclinical Brain Imaging Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 In Vivo Preclinical Brain Imaging Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global In Vivo Preclinical Brain Imaging Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global In Vivo Preclinical Brain Imaging Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global In Vivo Preclinical Brain Imaging Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global In Vivo Preclinical Brain Imaging Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global In Vivo Preclinical Brain Imaging Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global In Vivo Preclinical Brain Imaging Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global In Vivo Preclinical Brain Imaging Devices Sales by Region (2020-2025) & (Units)
 Table 8. Global In Vivo Preclinical Brain Imaging Devices Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global In Vivo Preclinical Brain Imaging Devices Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global In Vivo Preclinical Brain Imaging Devices Sales Share by Manufacturers (2020-2025)
 Table 12. Global In Vivo Preclinical Brain Imaging Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global In Vivo Preclinical Brain Imaging Devices Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global In Vivo Preclinical Brain Imaging Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Preclinical Brain Imaging Devices as of 2024)
 Table 16. Global In Vivo Preclinical Brain Imaging Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global In Vivo Preclinical Brain Imaging Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers In Vivo Preclinical Brain Imaging Devices Manufacturing Base and Headquarters
 Table 19. Global In Vivo Preclinical Brain Imaging Devices Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global In Vivo Preclinical Brain Imaging Devices Sales by Type (2020-2025) & (Units)
 Table 23. Global In Vivo Preclinical Brain Imaging Devices Sales by Type (2026-2031) & (Units)
 Table 24. Global In Vivo Preclinical Brain Imaging Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global In Vivo Preclinical Brain Imaging Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global In Vivo Preclinical Brain Imaging Devices ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global In Vivo Preclinical Brain Imaging Devices Sales by Application (2020-2025) & (Units)
 Table 29. Global In Vivo Preclinical Brain Imaging Devices Sales by Application (2026-2031) & (Units)
 Table 30. In Vivo Preclinical Brain Imaging Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global In Vivo Preclinical Brain Imaging Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global In Vivo Preclinical Brain Imaging Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global In Vivo Preclinical Brain Imaging Devices ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America In Vivo Preclinical Brain Imaging Devices Growth Accelerators and Market Barriers
 Table 37. North America In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America In Vivo Preclinical Brain Imaging Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe In Vivo Preclinical Brain Imaging Devices Growth Accelerators and Market Barriers
 Table 40. Europe In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe In Vivo Preclinical Brain Imaging Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Growth Accelerators and Market Barriers
 Table 45. Southeast Asia In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America In Vivo Preclinical Brain Imaging Devices Investment Opportunities and Key Challenges
 Table 47. Central and South America In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa In Vivo Preclinical Brain Imaging Devices Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa In Vivo Preclinical Brain Imaging Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. FUJIFILM Corporation Corporation Information
 Table 51. FUJIFILM Corporation Description and Major Businesses
 Table 52. FUJIFILM Corporation Product Models, Descriptions and Specifications
 Table 53. FUJIFILM Corporation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. FUJIFILM Corporation Sales Value Proportion by Product in 2024
 Table 55. FUJIFILM Corporation Sales Value Proportion by Application in 2024
 Table 56. FUJIFILM Corporation Sales Value Proportion by Geographic Area in 2024
 Table 57. FUJIFILM Corporation In Vivo Preclinical Brain Imaging Devices SWOT Analysis
 Table 58. FUJIFILM Corporation Recent Developments
 Table 59. Mediso Corporation Information
 Table 60. Mediso Description and Major Businesses
 Table 61. Mediso Product Models, Descriptions and Specifications
 Table 62. Mediso Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Mediso Sales Value Proportion by Product in 2024
 Table 64. Mediso Sales Value Proportion by Application in 2024
 Table 65. Mediso Sales Value Proportion by Geographic Area in 2024
 Table 66. Mediso In Vivo Preclinical Brain Imaging Devices SWOT Analysis
 Table 67. Mediso Recent Developments
 Table 68. Spectral Instruments Imaging Corporation Information
 Table 69. Spectral Instruments Imaging Description and Major Businesses
 Table 70. Spectral Instruments Imaging Product Models, Descriptions and Specifications
 Table 71. Spectral Instruments Imaging Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Spectral Instruments Imaging Sales Value Proportion by Product in 2024
 Table 73. Spectral Instruments Imaging Sales Value Proportion by Application in 2024
 Table 74. Spectral Instruments Imaging Sales Value Proportion by Geographic Area in 2024
 Table 75. Spectral Instruments Imaging In Vivo Preclinical Brain Imaging Devices SWOT Analysis
 Table 76. Spectral Instruments Imaging Recent Developments
 Table 77. MR Solutions Corporation Information
 Table 78. MR Solutions Description and Major Businesses
 Table 79. MR Solutions Product Models, Descriptions and Specifications
 Table 80. MR Solutions Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. MR Solutions Sales Value Proportion by Product in 2024
 Table 82. MR Solutions Sales Value Proportion by Application in 2024
 Table 83. MR Solutions Sales Value Proportion by Geographic Area in 2024
 Table 84. MR Solutions In Vivo Preclinical Brain Imaging Devices SWOT Analysis
 Table 85. MR Solutions Recent Developments
 Table 86. Charles River Laboratories Corporation Information
 Table 87. Charles River Laboratories Description and Major Businesses
 Table 88. Charles River Laboratories Product Models, Descriptions and Specifications
 Table 89. Charles River Laboratories Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Charles River Laboratories Sales Value Proportion by Product in 2024
 Table 91. Charles River Laboratories Sales Value Proportion by Application in 2024
 Table 92. Charles River Laboratories Sales Value Proportion by Geographic Area in 2024
 Table 93. Charles River Laboratories In Vivo Preclinical Brain Imaging Devices SWOT Analysis
 Table 94. Charles River Laboratories Recent Developments
 Table 95. Aspect Imaging Corporation Information
 Table 96. Aspect Imaging Description and Major Businesses
 Table 97. Aspect Imaging Product Models, Descriptions and Specifications
 Table 98. Aspect Imaging Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Aspect Imaging Recent Developments
 Table 100. Bruker Corporation Information
 Table 101. Bruker Description and Major Businesses
 Table 102. Bruker Product Models, Descriptions and Specifications
 Table 103. Bruker Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Bruker Recent Developments
 Table 105. MILabs Corporation Information
 Table 106. MILabs Description and Major Businesses
 Table 107. MILabs Product Models, Descriptions and Specifications
 Table 108. MILabs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. MILabs Recent Developments
 Table 110. Cubresa Corporation Information
 Table 111. Cubresa Description and Major Businesses
 Table 112. Cubresa Product Models, Descriptions and Specifications
 Table 113. Cubresa Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Cubresa Recent Developments
 Table 115. Key Raw Materials Distribution
 Table 116. Raw Materials Key Suppliers
 Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 118. Milestones in Production Technology Evolution
 Table 119. Distributors List
 Table 120. Market Trends and Market Evolution
 Table 121. Market Drivers and Opportunities
 Table 122. Market Challenges, Risks, and Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. In Vivo Preclinical Brain Imaging Devices Product Picture
 Figure 2. Global In Vivo Preclinical Brain Imaging Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. MRI Product Picture
 Figure 4. PET/SPECT Product Picture
 Figure 5. CT Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global In Vivo Preclinical Brain Imaging Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Alzheimer's Disease
 Figure 9. Parkinson's Disease
 Figure 10. Oncology
 Figure 11. Other
 Figure 12. In Vivo Preclinical Brain Imaging Devices Report Years Considered
 Figure 13. Global In Vivo Preclinical Brain Imaging Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 15. Global In Vivo Preclinical Brain Imaging Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global In Vivo Preclinical Brain Imaging Devices Revenue Market Share by Region (2020-2031)
 Figure 17. Global In Vivo Preclinical Brain Imaging Devices Sales (2020-2031) & (Units)
 Figure 18. Global In Vivo Preclinical Brain Imaging Devices Sales (CAGR) by Region (2020-2031) (Units)
 Figure 19. Global In Vivo Preclinical Brain Imaging Devices Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers In Vivo Preclinical Brain Imaging Devices Sales Volume Market Share in 2024
 Figure 21. Global In Vivo Preclinical Brain Imaging Devices Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. MRI Revenue Market Share by Manufacturer in 2024
 Figure 24. PET/SPECT Revenue Market Share by Manufacturer in 2024
 Figure 25. CT Revenue Market Share by Manufacturer in 2024
 Figure 26. Other Revenue Market Share by Manufacturer in 2024
 Figure 27. Global In Vivo Preclinical Brain Imaging Devices Sales Market Share by Type (2020-2031)
 Figure 28. Global In Vivo Preclinical Brain Imaging Devices Revenue Market Share by Type (2020-2031)
 Figure 29. Global In Vivo Preclinical Brain Imaging Devices Sales Market Share by Application (2020-2031)
 Figure 30. Global In Vivo Preclinical Brain Imaging Devices Revenue Market Share by Application (2020-2031)
 Figure 31. North America In Vivo Preclinical Brain Imaging Devices Sales YoY (2020-2031) & (Units)
 Figure 32. North America In Vivo Preclinical Brain Imaging Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) in 2024
 Figure 34. North America In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Type (2020- 2031)
 Figure 35. North America In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Application (2020-2031)
 Figure 37. North America In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe In Vivo Preclinical Brain Imaging Devices Sales YoY (2020-2031) & (Units)
 Figure 42. Europe In Vivo Preclinical Brain Imaging Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) in 2024
 Figure 44. Europe In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Type (2020-2031)
 Figure 45. Europe In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Application (2020-2031)
 Figure 47. Europe In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. France In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales YoY (2020-2031) & (Units)
 Figure 54. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Application (2020-2031)
 Figure 59. Asia-Pacific In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 64. India In Vivo Preclinical Brain Imaging Devices Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America In Vivo Preclinical Brain Imaging Devices Sales YoY (2020-2031) & (Units)
 Figure 66. Central and South America In Vivo Preclinical Brain Imaging Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Type (2021-2031)
 Figure 69. Central and South America In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Application (2020-2031)
 Figure 71. Central and South America In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil In Vivo Preclinical Brain Imaging Devices Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina In Vivo Preclinical Brain Imaging Devices Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa In Vivo Preclinical Brain Imaging Devices Sales YoY (2020-2031) & (Units)
 Figure 75. Middle East and Africa In Vivo Preclinical Brain Imaging Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Type (2021-2031)
 Figure 78. South America In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa In Vivo Preclinical Brain Imaging Devices Sales Volume (Units) by Application (2020-2031)
 Figure 80. Middle East and Africa In Vivo Preclinical Brain Imaging Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries In Vivo Preclinical Brain Imaging Devices Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey In Vivo Preclinical Brain Imaging Devices Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt In Vivo Preclinical Brain Imaging Devices Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa In Vivo Preclinical Brain Imaging Devices Revenue (2020-2025) & (US$ Million)
 Figure 85. In Vivo Preclinical Brain Imaging Devices Industry Chain Mapping
 Figure 86. Regional In Vivo Preclinical Brain Imaging Devices Manufacturing Base Distribution (%)
 Figure 87. Global In Vivo Preclinical Brain Imaging Devices Production Market Share by Region (2020-2031)
 Figure 88. In Vivo Preclinical Brain Imaging Devices Production Process
 Figure 89. Regional In Vivo Preclinical Brain Imaging Devices Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners